2,364 Shares in Koninklijke Philips (NYSE:PHG) Purchased by Millstone Evans Group LLC

Millstone Evans Group LLC acquired a new stake in Koninklijke Philips (NYSE:PHG) during the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 2,364 shares of the technology company’s stock, valued at approximately $60,000.

Other institutional investors also recently added to or reduced their stakes in the company. Wilmington Savings Fund Society FSB purchased a new stake in Koninklijke Philips in the 3rd quarter valued at approximately $54,000. Farther Finance Advisors LLC boosted its holdings in Koninklijke Philips by 37.1% in the 4th quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company’s stock valued at $54,000 after purchasing an additional 582 shares in the last quarter. Whipplewood Advisors LLC purchased a new stake in Koninklijke Philips in the 4th quarter valued at approximately $55,000. RPg Family Wealth Advisory LLC purchased a new stake in Koninklijke Philips in the 3rd quarter valued at approximately $107,000. Finally, Allworth Financial LP boosted its holdings in Koninklijke Philips by 24.9% in the 4th quarter. Allworth Financial LP now owns 3,993 shares of the technology company’s stock valued at $105,000 after purchasing an additional 797 shares in the last quarter. Hedge funds and other institutional investors own 13.67% of the company’s stock.

Koninklijke Philips Price Performance

PHG stock opened at $25.53 on Monday. The company has a current ratio of 1.23, a quick ratio of 0.74 and a debt-to-equity ratio of 0.59. Koninklijke Philips has a 12-month low of $19.10 and a 12-month high of $32.91. The company has a market cap of $24.00 billion, a price-to-earnings ratio of -30.39, a PEG ratio of 0.82 and a beta of 0.78. The firm has a 50 day moving average of $26.73 and a 200-day moving average of $27.71.

Koninklijke Philips (NYSE:PHG) last issued its quarterly earnings data on Wednesday, February 19th. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by ($0.01). Koninklijke Philips had a positive return on equity of 10.85% and a negative net margin of 3.88%. The company had revenue of $5.38 billion for the quarter, compared to analyst estimates of $5.10 billion. As a group, equities analysts expect that Koninklijke Philips will post 1.63 EPS for the current fiscal year.

Koninklijke Philips Cuts Dividend

The business also recently disclosed an annual dividend, which will be paid on Friday, June 6th. Investors of record on Tuesday, May 13th will be given a dividend of $0.886 per share. The ex-dividend date of this dividend is Tuesday, May 13th. This represents a dividend yield of 2.9%. Koninklijke Philips’s dividend payout ratio is currently -89.29%.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on PHG. Sanford C. Bernstein raised Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a report on Tuesday, March 18th. UBS Group upgraded shares of Koninklijke Philips from a “neutral” rating to a “buy” rating in a research report on Thursday, February 20th. BNP Paribas upgraded shares of Koninklijke Philips from a “neutral” rating to an “outperform” rating in a research report on Tuesday, February 25th. Finally, StockNews.com upgraded shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a research report on Saturday, March 8th. Two analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy”.

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.